{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:31Z","timestamp":1791910351909,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006087","name":"National Autonomous University of Mexico Directorate General of Academic Staff Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN214915"],"award-info":[{"award-number":["IN214915"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN223318"],"award-info":[{"award-number":["IN223318"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN220324"],"award-info":[{"award-number":["IN220324"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129223","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:42:26Z","timestamp":1791322946000},"page":"129223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessment of the Fasciola hepatica saposin-like protein 2 (rFhSAP2) vaccine candidate in sheep: Immunogenicity without protective efficacy"],"prefix":"10.1016","volume":"93","author":[{"given":"Adriana Ver\u00f3nica","family":"Balderas Loaeza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertha Josefina","family":"Espinoza Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cruz Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel Edmundo","family":"Villa Mancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Robles Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Quiroz Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Sahag\u00fan Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ortega Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129223_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1079\/JOH2005296","article-title":"Epidemiology of fascioliasis in human endemic areas","volume":"79","author":"Mas-Coma","year":"2005","journal-title":"J Helminthol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-308X(09)69002-3","article-title":"Chapter 2 Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control","volume":"69","author":"Mas-Coma","year":"2009","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0015","first-page":"13","article-title":"An update on the pathogenesis of fascioliasis: what do we know?","volume":"15","author":"Tanabe","year":"2024","journal-title":"Res Rep Trop Med"},{"key":"10.1016\/j.vaccine.2026.129223_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetpar.2015.01.004","article-title":"<i>Fasciola hepatica<\/i> vaccine: we may not be there yet but we\u2019re on the right road","volume":"208","author":"Molina-Hern\u00e1ndez","year":"2015","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0025","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/ani12121491","article-title":"Fasciolosis\u2014an increasing challenge in the sheep industry","volume":"12","author":"Stuen","year":"2022","journal-title":"Animals"},{"key":"10.1016\/j.vaccine.2026.129223_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00088-19","article-title":"Human and animal fascioliasis: origins and worldwide evolving scenario","volume":"35","author":"Mas-Coma","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.129223_bb0035","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/ani16071044","article-title":"Triclabendazole and other fasciolicides: resistance of Fasciola hepatica in ruminants","volume":"16","author":"Hou","year":"2026","journal-title":"Animals"},{"key":"10.1016\/j.vaccine.2026.129223_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2026.108087","article-title":"Dynamic immune modulation in fasciolosis: from protective to permissive responses","volume":"278","author":"Hurtado Marcos","year":"2026","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2026.129223_bb0045","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.pt.2022.09.009","article-title":"Omics tools enabling vaccine discovery against fasciolosis","volume":"38","author":"Cwiklinski","year":"2022","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0050","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.vaccine.2019.04.067","article-title":"Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep","volume":"37","author":"Ortega-Vargas","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129223_bb0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/vaccines13101008","article-title":"Evaluation of Quillaja brasiliensis saponin-based nanoparticles combined with leucine aminopeptidases for immunoprotection of sheep against Fasciola hepatica","volume":"13","author":"Checa","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129223_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2023.110049","article-title":"Fasciola hepatica antioxidant and protease-inhibitor cocktail recombinant vaccines administered five times elicit potent and sustained immune responses in sheep but do not confer protection","volume":"323","author":"Cwiklinski","year":"2023","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-4017(96)01131-4","article-title":"Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins","volume":"69","author":"Muro","year":"1997","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2025.110654","article-title":"Fasciola hepatica vaccine based on Kunitz-type molecule reduces adult worm fecundity in experimentally infected sheep","volume":"342","author":"Ahumada","year":"2026","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.vetpar.2009.12.018","article-title":"Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis","volume":"169","author":"Espino","year":"2009","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.actatropica.2013.08.012","article-title":"Differential expression and localization of saposin-like protein 2 of Fasciola hepatica","volume":"128","author":"Cab\u00e1n-Hern\u00e1ndez","year":"2013","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2026.129223_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1645\/GE-3113","article-title":"Molecular cloning of a member of the Fasciola hepatica saposin-like protein family","volume":"89","author":"Espino","year":"2003","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.diagmicrobio.2011.03.016","article-title":"Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis","volume":"70","author":"Figueroa-Santiago","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129223_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.actatropica.2017.03.002","article-title":"Expression, purification and in vitro refolding of the recombinant truncated Saposin-like protein 2 antigen for development of diagnosis of human fascioliasis","volume":"171","author":"Mirzadeh","year":"2017","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2026.129223_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exppara.2015.11.002","article-title":"Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica","volume":"160","author":"Rivera","year":"2016","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.exppara.2005.03.029","article-title":"Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice","volume":"110","author":"Espino","year":"2005","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exppara.2007.03.012","article-title":"Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5kDa Saposin-like protein SAP-2 using synthetic peptides","volume":"117","author":"Espino","year":"2007","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0115","article-title":"A modified variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a recombinant vaccine candidate induces high-avidity IgG2c antibodies and enhances T cell activation in C57BL\/6 mice","volume":"13","author":"Ramos-Nieves","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129223_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.47665\/tb.38.1.027","article-title":"Evaluation of antibody response of sheep to foot-and-mouth disease vaccine prepared by using different MontanideTM oil adjuvants","volume":"38","author":"\u00c7ok\u00e7al\u0131\u015fkan","year":"2021","journal-title":"Trop Biomed"},{"key":"10.1016\/j.vaccine.2026.129223_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01911","article-title":"The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant used","volume":"5","author":"Begg","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2026.129223_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152057","article-title":"Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB\/c mice","volume":"226","author":"Goyal","year":"2021","journal-title":"Immunobiol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0135","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1016\/j.vaccine.2013.05.078","article-title":"Montanide ISA\u2122 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle","volume":"31","author":"Dar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129223_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.vetpar.2010.04.042","article-title":"Immunoenhancing effects of Montanide ISA oil-based adjuvants on recombinant coccidia antigen vaccination against Eimeria acervulina infection","volume":"172","author":"Jang","year":"2010","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0145","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1645\/GE-3542RN.1","article-title":"Exposure to Fasciola hepatica miracidia increases the sensitivity of Lymnaea (Fossaria) humilis to high and low pH","volume":"92","author":"Cruz-Mendoza","year":"2006","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0150","series-title":"Fasciolosis II","first-page":"379","article-title":"Vaccines for Fasciola: new thinking for an old problem","author":"Spithill","year":"2021"},{"key":"10.1016\/j.vaccine.2026.129223_bb0155","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1016\/j.vaccine.2011.09.020","article-title":"The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep","volume":"29","author":"Maggioli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129223_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2025.110631","article-title":"Comparative analysis of the viability of Fasciola hepatica eggs collected from fecal and gallbladder samples in experimentally infected sheep","volume":"340","author":"Ortega-Vargas","year":"2025","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102355","article-title":"Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica","volume":"83","author":"Villa-Mancera","year":"2021","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2026.129223_bb0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijpara.2014.07.011","article-title":"Liver fluke vaccines in ruminants: strategies, progress and future opportunities","volume":"44","author":"Toet","year":"2014","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2019.109941","article-title":"The failure of a DNA prime\/protein boost regime and CTLA-4 mediated targeting to improve the potency of a DNA vaccine encoding Fasciola hepatica phosphoglycerate kinase in sheep","volume":"217","author":"Weso\u0142owska","year":"2019","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0180","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.vaccine.2018.02.115","article-title":"Vaccination of sheep with Quil-A\u00ae adjuvant expands the antibody repertoire to the Fasciola MF6p\/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes","volume":"36","author":"Orbegozo-Medina","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129223_bb0185","doi-asserted-by":"crossref","first-page":"15512","DOI":"10.1038\/s41598-025-00109-z","article-title":"Evaluation of a novel vaccine candidate derived from newly excysted juveniles of Fasciola hepatica in sheep","volume":"15","author":"Valderas-Garc\u00eda","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.129223_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104859","article-title":"Vaccination with cathepsin L mimotopes of Fasciola hepatica in goats reduces worm burden, morphometric measurements, and reproductive structures","volume":"155","author":"Villa-Mancera","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2026.129223_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.vetimm.2018.07.006","article-title":"Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica","volume":"202","author":"P\u00e9rez-Caballero","year":"2018","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0200","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0264-410X(97)00289-2","article-title":"Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica","volume":"16","author":"Mulcahy","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129223_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2020.109340","article-title":"Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep","volume":"289","author":"Villa-Mancera","year":"2021","journal-title":"Vet Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129223_bb0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13567-021-00895-0","article-title":"Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep","volume":"52","author":"Zafra","year":"2021","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2026.129223_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/pim.13074","article-title":"Safety and immunogenicity of an FhSAMS vaccine against Fasciola hepatica in dairy cattle","volume":"46","author":"Viana","year":"2024","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2026.129223_bb0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cvfa.2019.10.001","article-title":"Helminth vaccines in ruminants: from development to application","volume":"36","author":"Claerebout","year":"2020","journal-title":"Vet Clin North Am Food Anim Pract"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:23:12Z","timestamp":1791908592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S0264410X26010327"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129223","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the Fasciola hepatica saposin-like protein 2 (rFhSAP2) vaccine candidate in sheep: Immunogenicity without protective efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129223"}}